Nutex Health (NASDAQ:NUTX) President Acquires $23,705.64 in Stock

Nutex Health Inc. (NASDAQ:NUTX) President Warren Hosseinion bought 252 shares of the business’s stock in a transaction dated Thursday, March 19th. The stock was purchased at an average price of $94.07 per share, for a total transaction of $23,705.64. Following the acquisition, the president directly owned 7,765 shares of the company’s stock, valued at approximately $730,453.55. The trade was a 3.35% increase in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Nutex Health Trading Up 0.9%

NASDAQ:NUTX opened at $100.38 on Thursday. The company has a fifty day moving average of $116.07 and a 200 day moving average of $125.28. Nutex Health Inc. has a 52 week low of $45.88 and a 52 week high of $193.07. The company has a quick ratio of 3.39, a current ratio of 3.41 and a debt-to-equity ratio of 0.70. The firm has a market capitalization of $699.65 million, a P/E ratio of 11.18 and a beta of 0.03.

Nutex Health (NASDAQ:NUTX) last announced its quarterly earnings results on Thursday, March 5th. The company reported $1.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.56 by ($3.95). Nutex Health had a return on equity of 17.67% and a net margin of 7.34%.The firm had revenue of $151.68 million during the quarter, compared to the consensus estimate of $258.82 million.

Institutional Investors Weigh In On Nutex Health

Several institutional investors and hedge funds have recently modified their holdings of the stock. Pertento Partners LLP bought a new position in Nutex Health in the third quarter worth about $27,940,000. Topline Capital Management LLC boosted its position in Nutex Health by 80.0% during the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock valued at $57,505,000 after acquiring an additional 247,436 shares in the last quarter. Marshall Wace LLP boosted its position in Nutex Health by 333.4% during the 2nd quarter. Marshall Wace LLP now owns 94,548 shares of the company’s stock valued at $11,770,000 after acquiring an additional 72,734 shares in the last quarter. Millennium Management LLC grew its holdings in shares of Nutex Health by 191.1% during the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after acquiring an additional 61,308 shares during the period. Finally, Divisadero Street Capital Management LP purchased a new position in shares of Nutex Health during the 2nd quarter worth approximately $7,481,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on the company. Weiss Ratings restated a “hold (c)” rating on shares of Nutex Health in a report on Monday, December 29th. Wall Street Zen cut Nutex Health from a “strong-buy” rating to a “hold” rating in a report on Saturday, March 7th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Nutex Health currently has an average rating of “Moderate Buy” and a consensus price target of $252.50.

Nutex Health Company Profile

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.